Amber Thiel
Payments from drug & device makers
Across 279 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$610
- Novo Nordisk$391
- Amgen$313
- Phathom Pharmaceuticals, Inc.$245
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$241
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,700100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 70 | $1,180 |
| AstraZeneca | 19 | $610 |
| Novo Nordisk | 26 | $391 |
| Amgen | 19 | $313 |
| Phathom Pharmaceuticals, Inc. | 34 | $245 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $241 |
| Lilly USA, LLC | 13 | $200 |
| Otsuka America Pharmaceutical, Inc. | 10 | $172 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $143 |
| Medtronic | 8 | $134 |
| Boehringer Ingelheim | 8 | $134 |
| Gilead | 5 | $105 |
| GSK | 6 | $92 |
| Sumitomo Pharma America, Inc. | 4 | $81 |
| Axsome Therapeutics, Inc. | 3 | $80 |
| Exact Sciences | 3 | $60 |
| Pfizer | 4 | $55 |
| Verona Pharma, Inc. | 2 | $42 |
| Dexcom, Inc. | 2 | $41 |
| Inspire Medical Systems, Inc. | 1 | $34 |
| Biogen | 2 | $32 |
| Philips North America LLC | 2 | $31 |
| Organon | 2 | $31 |
| Lundbeck LLC | 1 | $24 |
| Bayer | 1 | $24 |
| Boston Scientific | 1 | $23 |
| Abbott | 1 | $23 |
| Grifols USA, LLC | 1 | $23 |
| Corcept Therapeutics | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Novartis | 1 | $17 |
| Johnson & Johnson | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,700 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 70 | $101,462 |
| EliquisApixaban | 80 | $63,118 |
| JardianceEmpagliflozin | 66 | $60,178 |
| FarxigaDapagliflozin Propanediol | 70 | $57,436 |
| RybelsusSemaglutide | 28 | $50,118 |
| JanuviaSitagliptin Phosphate | 30 | $33,383 |
| Breo ElliptaFluticasone/Vilanterol | 46 | $23,179 |
| TrulicityDulaglutide | 15 | $18,785 |
| LinzessLinaclotide | 30 | $15,462 |
| VascepaIcosapent Ethyl | 29 | $14,793 |
| Tresiba Flextouch U-100Insulin Degludec | 17 | $13,410 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 26 | $13,199 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 68 | $7,845 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $6,531 |
| Victoza 2-PakLiraglutide | 12 | $6,413 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $391 | $151,58198 claims |
| PfizerEliquis | $55 | $63,11880 claims |
| AstraZenecaFarxiga, Symbicort | $610 | $61,84582 claims |
| Boehringer IngelheimJardiance | $134 | $60,17866 claims |
| GSKBreo Ellipta, Anoro Ellipta | $92 | $36,37872 claims |
| Lilly USA, LLCTrulicity | $200 | $18,78515 claims |
| AbbVieLinzess, Synthroid | $1,180 | $16,67160 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,812 family providers in Ohio.
Other family in Lynx
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.